|Bid||3.98 x 0|
|Ask||4.04 x 0|
|Day's Range||3.9000 - 4.1900|
|52 Week Range||0.9262 - 9.8800|
|Beta (3Y Monthly)||1.63|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
/ The marijuana industry and marijuana stocks for that matter have been getting a lot of attention lately and it has begun to translate into new job growth. According to a new report from Vangst, a recruitment and job placement agency focused on the cannabis industry, these are some of the most popular jobs right now are legal cannabis cultivation and retail sales management. In addition to this, the cannabis industry is projected to grow by 220% in 2019 alone, according to the report.
MedMen Enterprises Inc. is pleased to announce that it has closed its previously announced acquisition of a dispensary license in Emeryville, California from B12, LLC.
Andrew Modlin (the “Acquiror”), the President and a director of MedMen Enterprises Inc. (the “Issuer”), each of the Acquiror and the Issuer being located at 10115 Jefferson Blvd, Culver City, CA 90232, announced today that on December 6, 2018 he acquired on the Canadian Securities Exchange 335,815 Class B Subordinate Voting Shares of the Issuer (the “Acquired Shares”) at an average price of C$3.901 per Acquired Share, for aggregate consideration of C$1,310,014. Prior to this transaction, Mr. Modlin held 3,956,324 Class B Common Shares (the “PC Corp Class B Shares”) of MM Can USA, Inc. (“PC Corp”), a subsidiary of the Issuer, 9,661,939 LTIP Units of MM Enterprises USA, LLC (the “LLC”), a subsidiary of PC Corp., and 815,295 Class A Super Voting Shares of the Issuer.
Adam Bierman (the “Acquiror”), the Chief Executive Officer and a director of MedMen Enterprises Inc. (the “Issuer”), each of the Acquiror and the Issuer being located at 10115 Jefferson Blvd, Culver City, CA 90232, announced today that on December 6, 2018 he acquired on the Canadian Securities Exchange 342,660 Class B Subordinate Voting Shares of the Issuer (the “Acquired Shares”) at an average price of C$3.905 per Acquired Share, for aggregate consideration of C$1,338,087. Prior to this transaction, Mr. Bierman held 3,956,324 Class B Common Shares (the “PC Corp Class B Shares”) of MM Can USA, Inc. (“PC Corp”), a subsidiary of the Issuer, 9,661,939 LTIP Units of MM Enterprises USA, LLC (the “LLC”), a subsidiary of PC Corp., and 815,295 Class A Super Voting Shares of the Issuer.
MedMen Enterprises Inc (CNSX:MMEN) has confirmed that it has closed the acquisition process of Omaha Management Services, LLC’s Monarch Dispensary. Omaha Management Services, a subsidiary of WhiteStar Solutions LLC, operated the Monarch Dispensary which happened to be the first cannabis dispensary of its kind in Scottsdale, Arizona. According to the terms of the agreement, MedMen will […] The post Medmen Enterprises Enters Arizona Cannabis Market Through Monarch Dispensary appeared first on Market Exclusive.
MedMen Enterprises Inc. announced today the hiring of Michael W. Kramer, a veteran finance executive with a proven track record at retailers such as Apple Inc., Abercrombie & Fitch and Forever 21, as Chief Financial Officer.
("MedMen" or the "Company") (MMEN.CN) (MMNFF) (FSE:A2JM6N) is pleased to announce that it has completed its previously-announced bought deal financing (the "Offering") of 13,640,000 units (the "Units") at a price of C$5.50 per Unit (the "Issue Price") for aggregate gross proceeds of C$75,020,000 . The Offering was conducted by way of a short form prospectus through a syndicate of underwriters led by Canaccord Genuity Corp., as lead underwriter, and including Eight Capital and Cormark Securities Inc. (collectively, the "Underwriters"). Each Unit consists of one Class B Subordinate Voting Share in the capital of the Company and one share purchase warrant of the Company (each, a "Warrant").
(“MedMen” or the “Company”) (MMEN.CN) (MMNFF) (FSE:A2JM6N) today announced that it has completed its acquisition of Omaha Management Services, LLC, for control of Monarch, a Scottsdale, Arizona-based licensed medical cannabis license holder with dispensary, cultivation and processing operations. The transaction, with WhiteStar Solutions LLC (“WhiteStar”), included the acquisition of WhiteStar’s exclusive co-manufacturing and licensing agreements with Kiva, Mirth Provisions and HUXTON for the state of Arizona. “As we look to operationalize the acquisitions we have made in recent months, our team has focused on timely and seamless transitions,” said Adam Bierman, MedMen chief executive and co-founder.
National footprint and solid performance position the Company to operationalize and optimize assets in premium markets
CORAL GABLES, FL / ACCESSWIRE / November 20,2018 / Marijuana stocks continue to grab more attention as the broader stock market has seen a strong sell-off this week. According toArcview Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry is poised for explosive growth. Total expenditure on legal marijuana worldwide is expected to hit $57 billion by 2027.
LOS ANGELES, CA , Nov. 19, 2018 /CNW/ - MedMen Enterprises Inc. (MMEN.CN)(MMNFF) ("MedMen" or the "Company") announces that, further to its press release dated November 16, 2018 , the Company has been issued a receipt by the applicable Canadian securities regulatory authorities for its preliminary prospectus dated November 16, 2018 (the "Preliminary Prospectus") in connection with its offering of 13,640,000 units ("Units"), at a price per Unit of $5.50 , for gross proceeds of $75,020,000 , to be issued and sold on a bought deal basis to a syndicate of underwriters, led by Canaccord Genuity Corp., and including Eight Capital and Cormark Securities Inc. (the "Offering"). Each Unit will be comprised of one Class B Subordinate Voting Share of the Company (each, a "Class B Share") and one Class B Share purchase warrant (each, a "Warrant").
The Company has amended the over-allotment option to allow for purchases up to an additional 2,046,000 Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. The over-allotment option may be exercised to acquire Units, Class B Shares, and/or Warrants of the Company.
USOTC:NWURF) has signed a definitive agreement (“the Agreement”) to sell the retail operations and license for a dispensary location in Santa Ana, California, through an all-stock transaction with MedMen Enterprises Inc. The store is currently MedMen branded and managed. “Through the sale of this dispensary we have achieved a strong return on our original investment for our shareholders,” said Captor Capital CEO, John Zorbas.
MedMen Enterprises Inc. announced today that Chief Financial Officer James Parker resigned, and that Jim Miller, the Company’s vice president of accounting, has been appointed interim chief financial officer until Parker’s successor is named.
MedMen Orange County is Currently Managed on behalf of Captor Capital Corp. MedMen Enterprises Inc. (“MedMen” or the “Company”) (MMEN.CN) (MMNFF) (FSE:A2JM6N) has signed a definitive agreement (the “Agreement”) to acquire the retail operations and license for a location in Santa Ana, California, through an all-stock transaction with Captor Capital Corp. (CPTR.CN). The store is currently MedMen branded and managed.
CORAL GABLES, FL / ACCESSWIRE / November 13, 2018 / Marijuana stocks have gotten even more popular following US midterm elections. This week, a number of cannabis stocks are slated to release earnings as well. According to Grand View Research, the global legal marijuana market is expected to reach $46.4 billion by end of 2025, according to a new report by Grand View Research, Inc. Growing adoption of marijuana in several medical applications such as cancer, mental disorders, chronic pain and others is expected to propel revenue growth in near future.
TORONTO, Nov. 13, 2018 -- Today, New Green Frontier, an invite-only, cannabis investor conference, is pleased to announce that Gene Simmons, legendary rock star, Chief.
The Company has agreed to grant the Underwriters an over-allotment option to purchase up to an additional 2,647,200 of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. The over-allotment option may be exercised to acquire Units, Class B Shares, and/or Warrants (as defined below) of the Company.
As of November 7, US Attorney General Jeff Sessions is out and an interim AG is in. Long thought of as a major hurdle for the cannabis industry, Sessions' departure has been seen as a positive marker for marijuana stocks. As the global market continues to expand, and the US possibly nears new legislation on cannabis, here are 3 marijuana stocks to watch.
Specific to the UK, investors may want to keep a close eye on the medical marijuana side of this industry. The global medical cannabis market size was estimated to be more than US$ 11 Billion in 2017. The cannabis market value is further expected to reach around US$ 37 Billion by 2023, exhibiting a CAGR of around 22% during 2017-2023 according to a report from Research And Markets.
CORAL GABLES, FL / ACCESSWIRE / November 1,2018 / The next wave of the marijuana green rush has "crossed the pond" and Britain now welcomes medical cannabis as a prescription option. As of November 1, "patients can be prescribed medicinal cannabis by specialist doctors," the Home Office said in a statement. ) announced today the implementation of its own, enterprise-level loyalty platform called "Leafbuyer Loyalty." The program will eventually fully integrate with the company’s much-anticipated blockchain and order-ahead initiatives.